Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Latera Randomized Controlled Trial (RCT) - Latera® Absorbable Nasal Implant vs. Sham Control for Lateral Nasal Valve Collapse

NCT03400787 is registered in ClinicalTrials.gov with Spirox, Inc. as lead sponsor.

NCT NCT03400787
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03400787 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Latera Randomized Controlled Trial (RCT) - Latera® Absorbable Nasal Implant vs. Sham Control for Lateral Nasal Valve Collapse
Lead sponsor
Spirox, Inc.
Phase
Not applicable
Overall status
Completed
Start date
November 28, 2017
Completion date
December 23, 2020
Enrollment
137 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

nasal breathing, nasal valve collapse